RMR boosts Covid treatments
Steroids to save lives
19 July 2021 | Local News
Anna Jonas, Erongo director of health; “The Ministry of Health welcomes the support from RMR in procuring methylprednisolone…”
Methylprednisolone and other steroid drugs have been linked to a 75% reduction in the chances of Covid-19 patients requiring mechanical ventilation or dying of the virus, if administered correctly.
Joint research by the Albert Einstein College of Medicine and Montefiore Health System found that patients with levels of C-reactive protein (CRP) higher than 20 were ideal for this treatment while those below the recommended levels were likely to increase associated risks by 200%.
CRP is a protein produced by the human liver in reaction to inflammation.
“The Ministry of Health welcomes the support from RMR in procuring methylprednisolone, a highly effective corticosteroid which augments the treatment we are providing to Covid-19 patients,” said Anna Jonas, the director of health in the Erongo region.
She warned against the dangers of laxity saying, “we certainly cannot afford to let our guard down in relation to the pandemic and especially in providing appropriate medicine at this crucial stage for Namibia”.
Martin Hirsch, RMR’s manager of resources and pre-development, said “We are committed to improving health through support to healthcare as part of our ongoing commitment to local communities. We are all in this together.”